Barclays PLC grew its position in Limoneira (NASDAQ:LMNR – Free Report) by 269.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,708 shares of the company’s stock after purchasing an additional 15,836 shares during the quarter. Barclays PLC owned approximately 0.12% of Limoneira worth $575,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. BNP Paribas Financial Markets lifted its stake in shares of Limoneira by 14.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,486 shares of the company’s stock valued at $92,000 after buying an additional 436 shares in the last quarter. State Street Corp raised its holdings in Limoneira by 3.7% during the third quarter. State Street Corp now owns 311,388 shares of the company’s stock valued at $8,252,000 after acquiring an additional 11,003 shares during the period. Global Alpha Capital Management Ltd. lifted its position in shares of Limoneira by 3.0% in the third quarter. Global Alpha Capital Management Ltd. now owns 3,299,703 shares of the company’s stock valued at $87,442,000 after acquiring an additional 96,054 shares in the last quarter. PEAK6 Investments LLC bought a new position in shares of Limoneira in the third quarter worth about $255,000. Finally, Riverwater Partners LLC grew its position in shares of Limoneira by 47.3% during the third quarter. Riverwater Partners LLC now owns 200,423 shares of the company’s stock worth $5,245,000 after purchasing an additional 64,392 shares in the last quarter. 64.35% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com cut Limoneira from a “hold” rating to a “sell” rating in a report on Wednesday, December 25th.
Limoneira Stock Performance
Shares of NASDAQ LMNR opened at $22.99 on Friday. The company has a market cap of $415.73 million, a P/E ratio of 60.50 and a beta of 0.52. Limoneira has a 52-week low of $17.37 and a 52-week high of $29.22. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.69 and a current ratio of 0.74. The firm’s fifty day moving average is $25.97 and its two-hundred day moving average is $24.75.
Limoneira Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Monday, December 30th were issued a $0.075 dividend. The ex-dividend date of this dividend was Monday, December 30th. This represents a $0.30 annualized dividend and a dividend yield of 1.30%. Limoneira’s dividend payout ratio (DPR) is 78.95%.
About Limoneira
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Valencia oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, and wine grapes.
See Also
- Five stocks we like better than Limoneira
- How to Most Effectively Use the MarketBeat Earnings Screener
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Buy P&G Now, Before It Sets A New All-Time High
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- How Investors Can Find the Best Cheap Dividend Stocks
- Micron Technology: Riding the AI Wave to Long-Term Growth
Want to see what other hedge funds are holding LMNR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Limoneira (NASDAQ:LMNR – Free Report).
Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.